NCT06569121 Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)
| NCT ID | NCT06569121 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Baylor Research Institute |
| Condition | Stroke, Acute |
| Study Type | INTERVENTIONAL |
| Enrollment | 94 participants |
| Start Date | 2024-12-07 |
| Primary Completion | 2027-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 94 participants in total. It began in 2024-12-07 with a primary completion date of 2027-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Investigators will conduct a randomized controlled trial (RCT) to assess intervention efficacy of telehealth delivery of the GLB-CVA (tGLB-CVA) compared to a 6-month wait-list control (WLC) in partnership with a diverse group of patient partners and peer mentors.
Eligibility Criteria
Inclusion Criteria: * Body Mass Index ≥25 * All types of stroke * Able to Participate in Physical Activity * ≥12 months post first stroke * Have internet, phone, or computer access, or be willing to use one provided by the study team Exclusion Criteria: * Contraindications for physical activity * Low Cognitive Function * Residing in hospital, acute rehab, skilled nursing facility * Not fluent in the English language * Pre-existing eating disorder * Pregnancy
Frequently Asked Questions
Who can join the NCT06569121 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Stroke, Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06569121 currently recruiting?
Yes, NCT06569121 is actively recruiting participants. Visit ClinicalTrials.gov or contact Baylor Research Institute to inquire about joining.
Where is the NCT06569121 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT06569121 clinical trial?
NCT06569121 is sponsored by Baylor Research Institute. The trial plans to enroll 94 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.